Pfizer Exits Early Neuroscience, But M&A Could Allow Later Re-Entry

 
• By Sten Stovall
  
Nerve cells
Analysts Unsurprized By Pfizer Exiting Early Neuroscience R&D • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business